Projects
Sylvie Blond: "Biotechnology in Neurodegenerative Disorders and Cancer Therapeutics"
Michael Johnson, Alexander Mankin, Andrew Mesecar, Bernie Santarsiero: "Novel Therapeutics for Bacillus anthracis"
Michael Johnson and Andrew Mesecar: "Novel Protease Inhibitors as SARS Therapeutics"
Andrew Mesecar: “Novel Organophosphorous Hydrolases for Decontamination"
Michael Johnson, Alexander Mankin, and Andrew Mesecar: A one-year, $880,000, grant from the U. S. Department of Defense will fund the College's new "Institute for Advanced Pharmaceutical Sciences".